Blair William & Co. IL lessened its stake in shares of Centene Co. (NYSE:CNC – Free Report) by 13.5% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 32,569 shares of the company’s stock after selling 5,065 shares during the period. Blair William & Co. IL’s holdings in Centene were worth $2,159,000 as of its most recent filing with the SEC.
Other hedge funds have also recently bought and sold shares of the company. Swedbank AB acquired a new stake in shares of Centene in the 1st quarter valued at approximately $914,080,000. Harris Associates L P grew its position in shares of Centene by 172.8% in the 4th quarter. Harris Associates L P now owns 10,863,367 shares of the company’s stock valued at $806,170,000 after acquiring an additional 6,881,450 shares during the period. Boston Partners raised its holdings in shares of Centene by 0.4% in the 1st quarter. Boston Partners now owns 8,652,177 shares of the company’s stock valued at $678,033,000 after purchasing an additional 32,427 shares during the period. Bank of New York Mellon Corp lifted its stake in Centene by 0.5% in the 2nd quarter. Bank of New York Mellon Corp now owns 5,491,968 shares of the company’s stock valued at $364,117,000 after purchasing an additional 25,595 shares during the last quarter. Finally, Capital International Investors increased its position in Centene by 60.2% during the first quarter. Capital International Investors now owns 5,216,486 shares of the company’s stock worth $409,390,000 after buying an additional 1,959,460 shares during the last quarter. 93.63% of the stock is currently owned by institutional investors.
Centene Price Performance
Centene stock opened at $75.61 on Monday. The stock’s fifty day moving average price is $74.48 and its two-hundred day moving average price is $73.46. The firm has a market cap of $40.35 billion, a PE ratio of 15.03, a price-to-earnings-growth ratio of 0.99 and a beta of 0.48. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.17 and a quick ratio of 1.17. Centene Co. has a one year low of $63.45 and a one year high of $81.42.
Wall Street Analysts Forecast Growth
CNC has been the subject of several research analyst reports. TD Cowen lifted their target price on Centene from $80.00 to $89.00 and gave the stock a “buy” rating in a research note on Wednesday, July 31st. Cantor Fitzgerald reiterated an “overweight” rating and issued a $90.00 price objective on shares of Centene in a report on Friday. Deutsche Bank Aktiengesellschaft lifted their target price on shares of Centene from $82.00 to $87.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Robert W. Baird assumed coverage on shares of Centene in a report on Thursday, May 30th. They issued a “neutral” rating and a $83.00 price target on the stock. Finally, Truist Financial reduced their price objective on Centene from $92.00 to $89.00 and set a “buy” rating for the company in a report on Monday, July 15th. Seven investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $85.58.
Check Out Our Latest Stock Analysis on Centene
About Centene
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.
Read More
- Five stocks we like better than Centene
- 3 Grocery Stocks That Are Proving They Are Still Essential
- 3 Stocks That Could Rise on European Bank Interest Rate Cuts
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- Differences Between Momentum Investing and Long Term Investing
- MarketBeat Week in Review – 9/16 – 9/20
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Co. (NYSE:CNC – Free Report).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.